Medigen gets funds from global foundation for mix-and-match booster trials
12/02/2021 10:51 PM
Taiwanese pharmaceutical company Medigen Vaccine Biologics Corp. said Thursday that it has received a US$2.3 million grant from an international foundation to fund trials of its COVID-19 vaccine as a potential booster.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Culture
Taiwanese writer Peng Ko dies aged 100
07/02/2025 10:57 PM - Business
Taiwan to help industries facing exchange rate fluctuations
07/02/2025 10:35 PM - Politics
2 more KMT lawmakers to face recall votes on Aug. 23
07/02/2025 10:32 PM - Society
Worker dies after falling unconscious at Taoyuan CPC Corp. facility
07/02/2025 09:58 PM - Politics
Taiwan, U.S. face 'bumps' in ongoing tariff talks: VP
07/02/2025 09:58 PM